In order to stimulate excellent research, the "Southern Norway Regional Health Authority" ("Helse Sør RHF") rewards outstanding publications every half-year. A paper with Fang Liu from Eivind Hovig's group as first author was chosen as one of the two winners in the category "basic research" for the second part of 2006.
The article, entitled "A sequence-oriented comparison of gene expression measurements across different hybridization-based technologies", was published in the July issue of top rated journal "Nature Biotechnology" (impact factor 22,7).
Below is a summary of the findings, written by Fang Liu, as well as information about the bioinformatics group and about Fang Liu herself, written by Eivind Hovig.
From major journals, first or last author from the Institute for Cancer Research
Lund-Andersen C, Torgunrud A, Kanduri C, Dagenborg VJ, Frøysnes IS, Larsen MM, Davidson B, Larsen SG, Flatmark K(2024) Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer J Transl Med, 22(1), 646 DOI 10.1186/s12967-024-05467-2, PubMed 38982444
Hammer Q, Perica K, Mbofung RM, van Ooijen H, Martin KE, Momayyezi P, Varady E, Pan Y, Jelcic M, Groff B, Abujarour R, Krokeide SZ, Lee T, Williams A, Goodridge JP, Valamehr B, Önfelt B, Sadelain M, Malmberg KJ(2024) Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies Cell Stem Cell(in press) DOI 10.1016/j.stem.2024.06.011, PubMed 38981470
Andresen NK, Røssevold AH, Borgen E, Schirmer CB, Gilje B, Garred Ø, Lømo J, Stensland M, Nordgård O, Falk RS, Mathiesen RR, Russnes HG, Kyte JA, Naume B(2024) Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials Mol Oncol(in press) DOI 10.1002/1878-0261.13675, PubMed 38978352
Lê Quý K, Chernigovskaya M, Stensland M, Singh S, Leem J, Revale S, Yadin DA, Nice FL, Povall C, Minns DH, Galson JD, Nyman TA, Snapkow I, Greiff V(2024) Benchmarking and integrating human B-cell receptor genomic and antibody proteomic profiling NPJ Syst Biol Appl, 10(1), 73 DOI 10.1038/s41540-024-00402-z, PubMed 38997321
Lund-Andersen C, Torgunrud A, Kanduri C, Dagenborg VJ, Frøysnes IS, Larsen MM, Davidson B, Larsen SG, Flatmark K(2024) Novel drug resistance mechanisms and drug targets in BRAF-mutated peritoneal metastasis from colorectal cancer J Transl Med, 22(1), 646 DOI 10.1186/s12967-024-05467-2, PubMed 38982444
Andresen NK, Røssevold AH, Borgen E, Schirmer CB, Gilje B, Garred Ø, Lømo J, Stensland M, Nordgård O, Falk RS, Mathiesen RR, Russnes HG, Kyte JA, Naume B(2024) Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials Mol Oncol(in press) DOI 10.1002/1878-0261.13675, PubMed 38978352